{
  "docId": "019de074-461e-7658-adac-5d98e29da216",
  "docSlug": "6158bdf12351a4a226761fe3aa786b96",
  "documentTitle": "Alkermes | Results Presentation Deck | 24 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 24,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "The chart tracks TRx (Total Prescriptions) over 67 weeks.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-461e-7658-adac-5d98e29da216/6",
  "deckHref": "/decks/019de074-461e-7658-adac-5d98e29da216",
  "deckJsonHref": "/decks/019de074-461e-7658-adac-5d98e29da216.json",
  "deckAnchorHref": "/decks/019de074-461e-7658-adac-5d98e29da216#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.6,
        "x": 0.05,
        "y": 0.235
      },
      "kind": "chart",
      "text": "Post-Launch TRx by Week",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a83af877-ac7c-413f-ae55-c07783914c71",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.28,
        "x": 0.68,
        "y": 0.3
      },
      "kind": "paragraph",
      "text": "Q4’22 total TRx: ~28,400 reflecting 23% sequential growth compared to Q3’22. ~7,600 prescribers had written a prescription for LYBALVI (as of 12/31/22) since launch reflecting 27% increase since Q3’22",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f1376286-4a0e-404f-860f-9bddb01333b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.05,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "*Source: IQVIA NPA Weekly",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e7974a41-836b-4212-9ae0-a4e67102b89f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "LYBALVI® Prescription Growth Trends",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f1f5efcf-535b-4115-a751-65efcfdc2b5d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chartjunk Elimination",
      "slug": "chartjunk-elimination",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "448452f1-9cd5-4f15-b072-13e5dd4cf3b2",
      "evidence": "chart/line: Post-Launch TRx by Week",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}